Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity-Reference-Cited by-同舟云学术

Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity

Published:2024-07-31 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Dupuis Joséphine¹^ORCID,Tauber Marie²³^ORCID,Mahe Emmanuel⁴^ORCID,Jachiet Marie⁵^ORCID,Soria Angèle⁶^ORCID,Tetart Florence⁷^ORCID,Puzenat Eve⁸^ORCID,Pasteur Justine⁹,Raison‐Peyron Nadia¹⁰,Giordano‐Labadie Françoise¹¹,Droitcourt Catherine¹²^ORCID,Leleu Camille¹³,Nosbaum Audrey³,Aubert Hélène¹⁴^ORCID,Moigne Marie L. E.¹⁴,Bernier Claire¹⁴,Barbarot Sébastien¹⁵^ORCID,Ezzedine Khaled¹⁶^ORCID,Diaz Emmanuelle¹⁶,Hubiche Thomas¹⁷,Faiz Sarah¹⁸,Azib Selma¹,Dezoteux Frederic¹¹⁹^ORCID,Chosidow Olivier²⁰^ORCID,Staumont‐Salle Delphine¹¹⁹^ORCID,

Affiliation:

1. CHU Lille, Service de Dermatologie Lille France

2. Service de Dermatologie, Hôpital Larrey, CHU de Toulouse Toulouse France

3. Allergologie et Immunologie Clinique, Hôpital Lyon‐Sud, CIRI Inserm U1111 Lyon France

4. Service de Dermatologie, Hôpital Victor Dupouy Argenteuil France

5. Dermatologie, Hôpital Saint‐Louis AP‐HP Paris France

6. Dermatologie et Allergologie, Hôpital Tenon AP‐HP Paris France

7. Dermatologie, CHU Rouen Rouen France

8. Dermatologie, CHU Besançon Besançon France

9. Dermatologie, CHU Clermont‐Ferrand Clermont‐Ferrand France

10. Dermatologie, C.H. U de Montpellier Montpellier France

11. Dermatologie, C.H. U de Toulouse Toulouse France

12. Department of Dermatology Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en santé, Environnement et Travail) ‐ UMR_S 1085 Rennes France

13. Dermatologie, Hôpital le Bocage Dijon France

14. Dermatologie, CHU Nantes Nantes France

15. Nantes Université, Department of Dermatology, CHU Nantes, INRAE, UMR 1280, PhAN Nantes France

16. Dermatologie, Hôpital Henri‐Mondor AP‐ HP Créteil France

17. Dermatologie, Hopital Archet 2 Nice France

18. Dermatologie, CH de Douai Douai France

19. Univ Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE) Lille France

20. Facial Dermatosis Clinic, AP‐HP, University‐Hospital La Pitié‐Salpêtrière Paris France

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20264

Reference8 articles.

1. Dupilumab pharmacokinetics in Chinese healthy subjects and patients with atopic dermatitis: Results of two randomized, double-blind, placebo-controlled studies

2. Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL‐4Rα, in Atopic Dermatitis Patients and Normal Volunteers

3. American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults

4. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

5. Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry